Published on 6 Nov 2022 on Simply Wall St. via Yahoo Finance
One of the biggest stories of last week was how Surgalign Holdings, Inc. (NASDAQ:SRGA) shares plunged 42% in the week since its latest quarterly results, closing yesterday at US$1.81. It was a moderately negative result overall - revenue fell 4.5% short of analyst estimates at US$20m, although at least statutory losses were marginally smaller than expected, at US$1.46 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.
Check out our latest analysis for Surgalign Holdings
earnings-and-revenue-growth